Revenue Breakdown
Composition ()
No data
Revenue Streams
Profitability & Margins
Evaluating the bottom line, Abeona Therapeutics Inc maintains a gross margin of 80.74%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -422.71%, while the net margin is -377.49%. These profitability ratios, combined with a Return on Equity (ROE) of 70.05%, provide a clear picture of how effectively ABEO converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ABEO competes directly with industry leaders such as CHRS and CNTX. With a market capitalization of $241.32M, it holds a leading position in the sector. When comparing efficiency, ABEO's gross margin of 80.74% stands against CHRS's 68.27% and CNTX's N/A. Such benchmarking helps identify whether Abeona Therapeutics Inc is trading at a premium or discount relative to its financial performance.
